Table 2

Clinicopathological profiles of endometrial intraepithelial carcinomas
Case EIC location Immunohistochemistry FIGO stage Outcome (periode)
P53a MIB-1b ERc PgRd
1 polyph + 30 + + IA DFi (66 months)
2 polyp & endometrium + 60 - - IA DF (65 months)
3f polyp & endometrium + 35 - - IA DF (36 months)
4 polyp + 30 - - IA DF (30 months)
5 polyph & endometrium + 45 - + IA DF (39 months)
6 polyp + 25 - - IA DF (39 months)
7 g polyp - 30 - - IA DODj (44 months)
8 polyph & endometrium - 70 - - IA DF (12 months)

a:+, strongly positive cells more than 80%.

b: index of positive cells(%), c: +, positive cells more than 80%.

d: +, positive cells more than 80%.

e: since initial diagnosis.

f: history of breast cancer with Tamoxifen administration.

g: autopsy performed.

h: with stromal invasion, i: disease free, j: death on disease.

Yasuda et al.

Yasuda et al. Diagnostic Pathology 2013 8:25   doi:10.1186/1746-1596-8-25

Open Data